Bio
Dr David Long completed his medical degree at the University of Melbourne in 2006. After working and training in the field of critical care and emergency medicine for nearly 10 years David decided to retrain in sport and exercise medicine and was awarded his fellowship of the Australasian College of Sport and Exercise Physicians in 2021. In addition to his clinic-based practice, David has more than 10 years experience as a team physician at elite level VFL/AFL clubs and for 6 years at elite level rugby union (Super Rugby). He has also provided medical coverage for a variety of other sporting codes including gymnastics, motor cross, cycling, and ultramarathon to name a few.
David is the current Chief Medical Officer with the Geelong Football Club. His special interests include acute injury management and the biomechanical basis of recurrent soft tissue injury in all sports. David also has a background in research having completed a Bachelor of Science with honours in anatomy and neuroscience and worked in neuroscience and diabetes research for 5 years. When not at work he enjoys time with his young children and continued involvement in musical endeavours as a compliment to his medical career.
Qualifications
Career Highlights / Affiliations / Associations
- Chief Medical Officer – Geelong Football Club (2021 – present)
- Match Day Doctor – Melbourne Rebels, Super 15 Rugby (2014-Present)
- Chief Medical Officer – Gymnastics Australia National Championships (2020 – 2021)
- Medical Officer Gymnastics Australia (2017-2019)
- Medical Officer – Brisbane Lions AFL Football Club (2017-2020)
- Medical Officer – Carlton Blues AFL Football Club (2014-2017)
- Chief Medical Officer – Northern Blues VFL Football Club (2014-2017)
- Senior Lecturer, Deakin University Medical School (2014-Present)
- Medical Officer – St Kilda AFL Football Club (2012-2014)
- Chief Medical Officer – Sandringham VFL Football Club (2012-2014)
Research / Publications
Cowan RM, Ganderton CL, Cook J, Semciw AI, Long DM, Pizzari T. Does Menopausal Hormone Therapy, Exercise, or Both Improve Pain and Function in Postmenopausal Women With Greater Trochanteric Pain Syndrome? A 2 × 2 Factorial Randomized Clinical Trial. The American Journal of Sports Medicine. December 2021. doi:1177/03635465211061142
Long DM, Fitzpatrick J. Safety and efficacy of a single intra-articular injection of hyaluronic acid in osteoarthritis of the hip: a case series of 87 patients. BMC Musculoskelet Disord. 2021 Sep 16;22(1):797. doi: 10.1186/s12891-021-04672-0. PMID: 34530784; PMCID: PMC8447787
Cornell K, De Souza A, Tacey M, Long DM, Veerasingham M. The effect of implementing a new guideline and operative pro forma on the detection and management of third- and fourth-degree perineal tears. Int J Womens Health. 2016 May 5;8:131-5. doi: 10.2147/IJWH.S101188.
Coughlan MT, Thallas-Bonke V, Pete J, Long DM, Gasser A, Tong DC, Arnstein M, Thorpe SR, Cooper ME, Forbes JM. Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy? Endocrinology. 2007 Feb;148(2):886-95.
Coughlan MT, Thallas-Bonke V, Pete J, Long DM, Gasser A, Tong DC, Arnstein M, Thorpe SR, Cooper ME, Forbes JM. Combination therapy with the AGE cross-link breaker, alagebrium and angiotensin converting enzyme inhibitors in diabetes: Synergy or redundancy? Endocrinology. 2006 Nov 16;
Forbes JM, Thorpe SR, Thallas-Bonke V, Pete J, Thomas MC, Deemer ER, Bassal S, El-Osta A, Long DM, Panagiotopoulos S, Jerums G, Osicka TM, Cooper ME. (2005) Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy. J Am Soc Nephrol. 2005Aug;16(8):2363-72. Epub 2005 Jun 1.
Lee FT, Cao Z, Long DM, Panagiotopoulos S, Jerums G, Cooper ME, Forbes JM. (2004) Interactions between angiotensin II and NF-kappaB-dependent pathways in modulating macrophage infiltration in experimental diabetic nephropathy. J Am Soc Nephrol. 2004 Aug;15(8):2139-51.
Forbes J.M, Soulis T, Thallas V, Panagiotopoulos S, Long D.M., Jerums G, Cooper M.E. (2001) Renoprotective effects of a novel inhibitor of advanced glycation. Diabetologia 2001 44:108-114.
Professional Conference Presentations
- Long, DM (2020) Safety and efficacy of a single intra-articular injection of hyaluronic acid in osteoarthritis of the hip: a case series of 87 patients.
- Long, DM (2016) Calcific Tendinopathy of the Rectus Femoris. ASCP National Conference
- Long, DM (2016) Acute and chronic knee pain. “Making waves” emergency services conference
- Long, DM (2015) Morton’s Neuroma: A review of current evidence in diagnosis and management. ASCP National Conference
- Long, D.M., Goodwin, A.W. and Wheat, H.E. (2000) SAI mechanoreceptive afferents convey information about force applied tangentially to the fingerpad. Proceedings of the Australian Neuroscience Society, Volume 11, p 213
- Forbes J.M, Soulis T, Thallas V, Panagiotopoulos S, Long D, Jerums G, Cooper M.E. (2001) Renoprotective effects of a novel inhibitor of advanced glycation. IDF, Mexico City
- Panagiotopoulos S, Forbes J.M, Soulis T, Thallas V, Long D, Jerums G, Cooper M.E. (2000). ALT 946, A novel inhibitor of advanced glycation, prevents albuminuria in experimental diabetes. ASN, Toronto
FEE STATEMENT AND ONLINE BOOKING
Melbourne and Telehealth Campus Fee Statement
A referral from a general or specialist medical practitioner is required to see Dr Long. The cost of an initial consultation with Dr Long will be up to $270 for an initial consultation, with a Medicare rebate of $76.80. The cost of a review consultation with Dr Long will be $170 with a Medicare rebate of $38.60. Initial consultations are generally booked as 40 minute appointments with review consultations 20 minutes unless otherwise specified by Dr Long in discussion with the patient. Additional costs may be incurred for longer appointment times. Please note that in addition to the charges already mentioned additional fees may apply for any investigations or interventions performed in the clinic. These additional fees may, in some cases, attract a Medicare rebate. Payment of all fees is required on the same day as the appointment. Please note that private health insurance does not cover out of hospital medical fees. For further information about fees and charges please contact OPSMC on 1300 859 887.
We do not bulk bill due to inadequate Medicare rebates.
Online Booking
Please choose a campus to view appointment availability and book online.